Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Spondylitis, Ankylosing × Herpes Zoster Vaccine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spondylitis, Ankylosing 1 Psoriasis 1 Crohn Disease 1 Arthritis, Rheumatoid 1 Arthritis, Psoriatic 1 Arthritis 1

Interventions

golimumab 1 Vaccines 1 Tumor Necrosis Factors 1 Sulfasalazine 1 Saline Solution 1 Meloxicam 1 Herpes Zoster Vaccine 1 Etoricoxib 1 Etanercept 1 Celecoxib 1 Anti-Inflammatory Agents, Non-Steroidal 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed

617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡